Pharmaceutical News

RSS

Study to determine if treating mothers can help children at risk for ADHD

University of Illinois at Chicago researchers are conducting a study to determine if treating mothers with Attention Deficit Hyperactivity Disorder -- either with medication or parent training -- will help children at risk for ADHD.

19 Oct 2012

Zimbabwe to allow trained nurses to prescribe, administer ARVs

PlusNews examines challenges and concerns over an announcement by the Zimbabwean government that it plans to train nurses to prescribe and administer antiretroviral drugs (ARVs) to people living with HIV in the country.

19 Oct 2012

Islamic Azad University develops new medicated gum for motion sickness

A new prototype for medicated chewing gum has been developed for motion sickness that may offer many advantages over conventional oral solid dosage forms. About 33 percent of people are susceptible to motion sickness in mild circumstances and 66 percent are affected in more severe conditions.

19 Oct 2012

TB Alliance and FIND partner to promote development of TB drugs and diagnostics

A new partnership announced today will increase efforts to coordinate the development of complementary novel tools to fight TB, including drug-resistant TB, and identify emerging drug resistance trends around the globe.

19 Oct 2012

Chelsea Clinton in Nigeria to promote program distributing zinc, oral rehydration solutions

"Chelsea Clinton is taking on the discomforting issue of diarrhea, throwing her family's philanthropic heft behind a sweeping effort in Nigeria to prevent the deaths of one million mothers and children each year from preventable causes, including 100,000 deaths from diarrhea," Reuters reports.

19 Oct 2012

Daily sedation interruption does not benefit critically ill, mechanically ventilated patients

For critically ill patients receiving mechanical ventilation, daily sedation interruption did not reduce the duration of mechanical ventilation or appear to offer any benefit to patients, and may have increased both sedation and analgesic use and nurse workload, according to a study appearing in JAMA.

19 Oct 2012

Kids with ADHD tend to feel that they benefit from medications

Children living with attention deficit hyperactivity disorder (ADHD) tend to feel that they benefit from medication to treat the condition and do not feel that the medication turns them into 'robots', according to a report published today. In fact, they report feeling that medication helps them to control their behaviour and make better decisions.

19 Oct 2012

Scientists report on development of new malaria drug

Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective as the best current medicine against this global scourge and may fight off the disease with one dose, instead of the multiple doses that people often fail to take.

18 Oct 2012

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.

18 Oct 2012

Study examines long-term affect of multivitamins on major chronic diseases

A daily multivitamin can help a man reduce his risk of cancer, according to new research from Brigham and Women's Hospital.

18 Oct 2012

Trial results of first new TB vaccine candidate in 90 years expected next year

"Researchers will find out early next year whether the first new vaccine against tuberculosis [TB] for 90 years protects against a disease that was once neglected but is now resurgent worldwide," Financial Times reports.

18 Oct 2012

NPR examines efforts to eradicate polio in Nigeria

NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 -- or nearly three times as many as in the same period last year."

18 Oct 2012

Additional drugs linked to meningitis outbreak

Food and Drug Administration officials said Monday that more people may be at risk as a result of contaminated drugs made by a Massachusetts compounding pharmacy.

17 Oct 2012

Prescription pain medication abuse on the rise among current generation of adolescents

A new study by the University of Colorado Denver reveals that today's adolescents are abusing prescription pain medications like vicodin, valium and oxycontin at a rate 40 percent higher than previous generations.

17 Oct 2012

FDA accepts A.P. Pharma’s resubmission of NDA for APF530

A.P. Pharma, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company's resubmission of its New Drug Application (NDA) for APF530.

17 Oct 2012

Novel drug increases survival in animal models exposed to high-dose radiation

A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D., from the University of Tennessee Health Science Center and Baylor College of Medicine, show that application of this drug, starting 24 hours after radiation exposure, increases survival in animal models by three-fold compared to placebo.

17 Oct 2012

Benzocaine oral strip immediately relieves pain from burns

A dissolvable oral strip has been developed to immediately relieve pain from burns caused by ingestion of hot foods and liquids, such as coffee, pizza, and soup. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Chicago, Ill., on Oct. 14 - 18.

17 Oct 2012

BioLineRx completes pre-clinical development of BL-8020 for HCV

BioLineRx, a biopharmaceutical development company, announced today that it has successfully completed the pre-clinical development of BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus (HCV), and plans to commence a Phase I/II safety and efficacy study for BL-8020 in Europe during the first quarter of 2013.

17 Oct 2012

Positive results from PROLOR's Rpeg preclinical toxicology study

PROLOR Biotech, Inc. today announced positive results from a preclinical toxicology study designed to assess the safety and tolerability of PROLOR's proprietary long-acting reversible-pegylation technology.

17 Oct 2012

Offering methadone treatment to drug users significantly reduces HIV infection, transmission risk, study shows

Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.

17 Oct 2012